info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_OVARY_SEROUS_EXALLC for full statistics.

Serous carcinoma of ovary

C3_OVARY_SEROUS

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector
diagram bullet

Apply sex-specific rule

Sex only females

219462

diagram downward connector

Check conditions None

219462

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 C56.71&
Cause of death: ICD-10 C56.71&
Cancer registry: Topography ICD-O-3 C56
Cancer registry: Morphology ICD-O-3 8441
Cancer registry: Behaviour codes 3

3 out of 7 registries used, show all original rules.

891

diagram downward connector

Check minimum number of events None

891

diagram downward connector

Include endpoints None

891

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

852

diagram downward connector
C3_OVARY_SEROUS

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF9

Similar endpoints

List of similar endpoints to Serous carcinoma of ovary based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 852 852 -
Unadjusted prevalence (%) 0.23 0.40 -
Mean age at first event (years) 62.00 62.00 -

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: C3_OVARY_SEROUS – Serous carcinoma of ovary
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Serous carcinoma of ovary

Endpoint not on priority list, no data to show.